Fig. 3: Prognostic scores in ccRCC.
From: Evidence of DNA methylation heterogeneity and epipolymorphism in kidney cancer tissue samples
Gene expression is visualised for genes which contribute to the Clearcode34 prognostic risk score (A). Expression was derived from RNA-seq and is median centred and presented on a log2 scale. Multi-region samples from the same patient are shown, along with recurrence status. Leibovich score for patients that did not have a recurrence versus patients who either had metastases at diagnosis or developed recurrence on follow up (B). Each dot represents a patient, where the colour of the dot shows tumour stage (stage I-IV). Individual Leibovich scores can be aggregated into three groups: low (0–2), intermediate (3–5) and high (≥6).
